STAT

STAT+: Once again, child dies in gene-editing trial in China, rekindling debate on transparency and safety

STAT+: Once again, child dies in gene-editing trial in China, rekindling debate on transparency and safetyWorldPing

With a second delayed report of a child's death in China, criticism is rising of a looser form of clinical trial.One expert: what "bothers me is the lack of…

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

Related news